Merck KGaA

Company Snapshot

Founded: 1668

Entity Type: Public

Employees: 62,557

Region: Asia-Pacific

Revenue: $22,895.3 Millions

Revenue Year: 2024

Segment: Life Science

Headquarter: Darmstadt, Germany

Key Geographics: Europe, North America, Latin America, Middle East & Africa, Asia-Pacific

Corporate Address: Frankfurter Strasse 250 Darmstadt, 64293, Germany Tel. +49-615-1720 www.merckgroup.com

Company Overview

Merck KGaA, with its headquarters in Darmstadt, Germany, is a science and technology leader operating in Healthcare, Life Science, and Electronics. Founded in 1668, it is the world's oldest pharmaceutical and chemical company, with operations in more than 65 countries and approximately 62,000 employees.

The Healthcare division develops innovative therapies, the Life Science segment provides tools and services for scientific research, and the Electronics division supplies advanced materials for digital technologies. The company is owned by the Merck family through 70.3% ownership, while the company operates under the name "EMD" in the United States and Canada due to differences in trademark.

Financial Highlights (FY 2024)

Net Revenue: ***

Total Current Liabilities: ***

Total Current Assets: ***

R&D expenses: ***

Operating Income: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Merck KGaA In Reports

Global Thyroid Gland Disorders: Diagnostics and Treatment Market

Our detailed report on the Thyroid Gland Disorder Market trends It includes global revenue ($ Million) for the base year of 2023 and estimated data for the forecast period 2024 through 2029.

Oncology Diagnostics: Global Markets

BCC Research Report: Dive into oncology diagnostics market revenues can be estimated based on the product category, by application, by end user and by region.

Proteomics: Technologies and Global Markets

According to BCC Research proteomics market includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

View All Reports

Merck KGaA In News

德國默克39億美元收購美國生物製藥公司SpringWorks(SWTX.US) - AASTOCKS.com

AASTOCKS.com - Apr 28, 2025

CSF-1R療法升溫！默克再斥8500萬美元取上海和譽候選藥全球權利 - 環球生技月刊

環球生技月刊 - Apr 02, 2025

市場報導：默克投資台灣5年170億台幣投入半導體前瞻材料研發 - 科技產業資訊室

科技產業資訊室 - Mar 27, 2025

生技｜德國默克集團想併購美國生技公司Springworks，搶攻癌症與罕見病領域的成長機遇！ - 優分析UAnalyze

優分析UAnalyze - Feb 11, 2025

Read All News

Company's Business Segments

Life Science : Science & Lab Solutions, Process Solutions and Life Science Services
Healthcare : Oncology, Erbitux, Bavencio, Neurology & Immunology, Rebif, Mavenclad, Fertility, Gonal-f, Cardiovascular, Metabolism & Endocrinology
Electronics : Semiconductor Solutions, Display Solutions and Surface Solutions

Applications/End User Industries

Neurological Disorders
Immunological Diseases
Multiple Sclerosis
Reproductive Health And Fertility
Cardiovascular Diseases
Metabolic Disorders
Endocrine Disorders
Scientific Research
Laboratory Work
Reagents
Semiconductor Manufacturing
Liquid Crystals
Automotive Electronics
Electronic Applications
Consumer Electronics
Filtration Systems
Contract Research
Process Development
Biopharmaceutical Manufacturing

Therapies For Cancer Treatment
Oncology
Neurology & Immunology
Fertility
Endocrinology
Pharma Biotech
Diagnostics
Government & Academic Research
Industrial
Semiconductor Solutions
Display Solutions
Surface Solutions
Advancing Digital Living with Electronics
Healthcare Pipeline
Clinical Trials
Global R&D Hubs
Artificial Intelligence - AI Research
Global Health Institute

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.